April 24, 2026 Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology
April 24, 2026 Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock
April 24, 2026 Dream Pairs Kids Celebrates Mother’s Day 2026 with “Mommy & Me” Collection — Where Style Becomes a Shared Story
